News | News By Subject | News by Disease News By Date | Search News

Bronchitis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Pharmaxis Ltd (PXS.AX) Receives Approval to Market Bronchitol in the EU     4/27/2012
Adams Respiratory Therapeutics Says FDA Seeks More Data to OK Cough Drug     10/29/2007
Phase III Trial Finds Pharmaxis Ltd (PXS.AX)'s Bronchitol Effective; Two Primary Efficacy Endpoints Met     8/29/2007
FDA Approves Dey, L.P.'s Perforomist(TM) (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD     5/11/2007
Replidyne, Inc. Stops Bronchitis Drug Trial     12/26/2006
FDA Accepts As "Complete Response" Oscient Pharmaceuticals Corporation (OSCI)'s Submission Following FACTIVE Approvable Letter For Five-Day CAP     11/27/2006
Bristol-Myers Squibb Company (BMY) Announces Stronger Label Warnings For Tequin     2/16/2006
Pharmaxis Ltd (PXS.AX) Announces Bronchitol (TM) Approved For Patient Use Under Special Access Scheme     5/12/2005
FDA Approves Sepracor, Inc.'s (SEPR) XOPENEX HFA(TM) Metered-Dose Inhaler     3/14/2005
Patch's Pharmaceutical Interest Granted US FDA Approval For Aridol(TM) Phase III Trial     1/6/2005
Aventis S.A. (AVE) Announces FDA Approval Of KETEK(TM) (Telithromycin) Tablets     4/2/2004
GlaxoSmithKline (GSK) Release: FDA Approves New Treatment For Chronic Obstructive Pulmonary Disease (COPD) Associated With Chronic Bronchitis; Advair Diskus(R) 250/50 (Fluticasone Propionate 250 Mcg And Salmeterol 50 Mcg Inhalation Powder) Is the First And Only Product To Contain An Anti-Inflammatory And A Bronchodilator To Improve Lung Function     11/18/2003

News from Around the Web
Life Science Weekly inSite (Sep. 21 - 26)     9/29/2008
Cold Medication Use In Children Less Than Two Years Old Can Lead To Adverse Effects, Even Death, Children's Hospital Boston/Harvard Medical School Study     6/2/2008
Study Links Snoring to Chronic Bronchitis     1/29/2008
University of Liverpool Scientists Find Predisposition to Bronchiolitis in Some Babies     10/22/2007
Infants with Bronchiolitis May Benefit More from Albuterol     5/16/2007
Antibiotics Usually Useless For Bronchitis: Study     11/16/2006
New Vaccine Would Target Ear, Sinus Infections     9/26/2006
FDA Warns Three Pharmacies To Stop Mass-Producing Unapproved Inhalation Drugs     8/11/2006
Study Finds Antibiotics Rarely Help Deep Cough     6/22/2005
Johnny Carson Dies From Common Lung Disease     1/25/2005
Desert Shrub May Help Some Cancer Patients     8/11/2004

Press Releases
Therabron Release: Pharma Receives Orphan Drug Designation In The European Union For CG367, Indicated For The Treatment Of Bronchiolitis Obliterans Syndrome     1/24/2017
CSA Medical, Inc. Commences Phase B Of The RejuvenAir System Safety And Feasibility Study For The Treatment Of Chronic Bronchitis Patients     11/17/2016
CSA Medical, Inc. Announces The First Chronic Bronchitis Patient Treatments In The RejuvenAir System Safety And Feasibility Study     4/12/2016
Perrigo Company (PRGO) Announces Settlement In Proair® HFA Patent Case     6/20/2014
Invion Limited Announces Commencement of Phase 2 Chronic Bronchitis Clinical Trial     7/22/2013
INNOPHARMA Announces FDA Approval of Acetylcysteine Solution, USP, 20% for Inhalation or Oral Administration     9/19/2012
Aradigm Corporation (ARDM) Selects Pulmaquin™ for Phase 3 Development and Announces Issuance of its First U.S. Patent Covering Inhaled Ciprofloxacin Formulations     12/7/2011
Aradigm Corporation (ARDM) to Present Additional ORBIT-2 Clinical Trial Results at Respiratory Drug Delivery Europe 2011 Conference     5/3/2011
Abbott Canada Launches Oscient Pharmaceuticals Corporation (OSCI)' FACTIVE Tablets in Canada     3/2/2007
Quigley Pharma Inc. (QGLY) Broad Spectrum Anti-Viral QR-441(a) Shown To Be Effective Against Two Problematic Pathogens To The Poultry Industry     1/8/2007
Novartis Pharma K.K. (NVS) Files New Drug Application For Agent For Treating Bronchial Asthma     6/26/2006
Replidyne, Inc. Submits New Drug Application (NDA) For Orapem(TM) (Faropenem Medoxomil) To U.S. FDA     1/9/2006
Oscient Pharmaceuticals Corporation (OSCI) To Present Clinical Data On FACTIVE(R) Tablets At Chest 2005; Data Presentations Address Utility Of FACTIVE In High-Risk Patients And Against Resistant Infections     10/31/2005
Theravance, Inc. (THRX) Announces Results Of Phase 2 Clinical Study Showing 24-Hour Bronchodilation With Investigational Medicine     6/27/2005
Boehringer Ingelheim Corporation Release: New Study Shows Significant Improvements In Health-Related Quality-Of-Life Measures In Chronic Obstructive Pulmonary Disease Patients Using SPIRIVA(R) HandiHaler(R)     5/24/2005